Selected article for: "chain reaction and molecular method"
Author: Dachuan Lin; Lei Liu; Mingxia Zhang; Yunlong Hu; Qianting Yang; Jiubiao Guo; Youchao Dai; Yuzhong Xu; Yi Cai; Xinchun Chen; Kaisong Huang; Zheng Zhang
Title: Evaluations of serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak
  • Document date: 2020_3_30
    • ID: 6hep2lin_3
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101 /2020 such as TaqMan Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR), Enzyme-linked 65 immunosorbent assay, colloidal gold immunochromatography and direct chemiluminescence 66 immunoassay(CLIA), can be developed into a rapid and effective tool for detections of respiratory 67 pathogens infections, even though in certain circum.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101 /2020 such as TaqMan Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR), Enzyme-linked 65 immunosorbent assay, colloidal gold immunochromatography and direct chemiluminescence 66 immunoassay(CLIA), can be developed into a rapid and effective tool for detections of respiratory 67 pathogens infections, even though in certain circumstances molecular biologic method like RT-PCR 68 had a low sensitivity for specimens from upper respiratory tract (14-17). 69 In this study, we developed a chemiluminescence immunoassay method to specifically detect the CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC International license and low sensitivity: 1
    • cc NC International license and pathogen infection: 1, 2, 3
    • cc NC International license and Real time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC International license and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC International license and upper respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • colloidal gold immunochromatography and gold immunochromatography: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • colloidal gold immunochromatography and pathogen infection: 1
    • colloidal gold immunochromatography and Real time: 1, 2, 3
    • effective rapid tool and low sensitivity: 1
    • effective rapid tool and Real time: 1, 2, 3, 4, 5, 6
    • gold immunochromatography and pathogen infection: 1
    • gold immunochromatography and Real time: 1, 2, 3, 4
    • immunoassay method and International license: 1, 2
    • immunoassay method and Real time: 1, 2, 3
    • immunoassay method and respiratory tract: 1
    • International license and Real time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • International license and respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • International license and upper respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10